Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sertraline for Depression and Anxiety in COPD and ILD Patients
NCT02813447Terminated
- Sponsor
- Duke University
- Start
- Aug 2016
- Primary completion
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in major depressive disorder (MDD), anxiety disorder and stress comparing Sertraline + Rehab with Placebo + Rehab (2 arms). Primary endpoints: Change in 6-minute walk distance at 12 weeks and University of California San Diego Shortness of Breath at 12 weeks. Started Aug 2016; status: terminated.
02
Drugs
sertraline
03
Conditions
major depressive disorder (MDD)anxiety disorderstress
Beyond the preview
Go deeper on NCT02813447.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02813447.